Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine.

The article titled "Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine" has been retracted by the editors of Scientific Reports. The retraction was made due to concerns about overlapping data with other articles and the inability of the authors to provide raw data. The editors no longer have confidence in the results presented in the article. The authors of the retracted article are Fang Xie, Mei Huang, Xiansheng Lin, Chenhai Liu, Zhen Liu, Futao Meng, Chao Wang, and Qiang Huang. [Extracted from the article]